Oncopeptides AB (publ) (LON:0RN4)
London
· Delayed Price · Currency is GBP · Price in SEK 1.950
+0.034 (1.75%)
At close: Apr 25, 2025
Oncopeptides AB Revenue
In the year 2024, Oncopeptides AB had annual revenue of 31.65M SEK, down -10.14%. Oncopeptides AB had revenue of 9.91M in the quarter ending December 31, 2024, with 85.76% growth.
Revenue
31.65M SEK
Revenue Growth
-10.14%
P/S Ratio
14.84
Revenue / Employee
395.60K SEK
Employees
80
Market Cap
33.91M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| British American Tobacco p.l.c. | 25.87B |
| Rolls-Royce Holdings | 18.91B |